Imunon, Inc.
USD1.95
-0.01 (-0.68%)
CEO
Michael Tardugno
IPO Date
1993-10-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.96
Prev. Close
Day Low
$1.93
Day High
$1.99
Market Cap
$0.01B
Volume
0.06M
CELSION CORPORATION ANNOUNCES ADJOURNMENT OF ANNUAL MEETING
Celsion Corporation Urges All Shareholders to Vote at the 2021 Annual Meeting to be Held on Friday June 4, 2021
Celsion Corporation (CLSN) CEO Michael Tardugno on Q1 2021 Results - Earnings Call Transcript
Celsion Corporation Reports First Quarter 2021 Financial Results and Provides Business Update
Celsion Corporation to Hold First Quarter 2021 Financial Results and Business Update Conference Call on Friday, May 14, 2021
CELSION CORPORATION ANNOUNCES CLOSING OF $15 MILLION REGISTERED DIRECT OFFERING
Celsion's Ovarian Cancer Immunotherapy Shows 41% Improvement In R0 Resection Rates